Extended Research →
Verdict, decision matrix, deep dives, sourcing notes & full sources

Ashwagandha Sensoril

Root + leaf ashwagandha extract standardized to ~10% withanolides, licensed by Natreon (US-based), and the substrate of the strongest sleep + anxiety trials in the ashwagandha literature. | Compound

Aliases (4)
Sensoril · Natreon Sensoril · Sensoril Ashwagandha · Withania somnifera root + leaf extract
TYPICAL DOSE
125-250 mg evening with food
ROUTE
CYCLE
STORAGE
Did you know? You can suggest edits to improve this compound's information.
Submitted via email — no account required.
Suggest an edit
Overview TL;DR

Root + leaf ashwagandha extract standardized to ~10% withanolides, licensed by Natreon (US-based), and the substrate of the strongest sleep + anxiety trials in the ashwagandha literature. Higher withaferin A content than KSM-66 (from leaf inclusion) — more sedating, more anxiolytic-skewed, slightly higher autoimmune-flare risk (theoretical). For Dylan: OPTIONAL-ADD low priority — V4 sleep stack is robust; KSM-66 better fits Dylan's AM-friendly profile if any ashwagandha is added. Parent file ashwagandha.md has full pharmacology — this file focuses on Sensoril-specific differences.

Mechanism of action

Same general mechanism as parent. Sensoril-specific notes:

  • Root + leaf extraction: Includes leaf material → higher withaferin A (the more potent and more cytotoxic withanolide). Withaferin A is a known immunomodulator and Nrf2 activator.
  • ~10% withanolide standardization: Higher concentration than KSM-66's ~5%, allowing lower mg dosing.
  • Sleep + anxiolysis dominance: The withaferin A enrichment and overall higher withanolide load skew the subjective and biomarker profile toward sedation and anxiolysis.
  • Pharmacokinetics: Similar withanolide A peak/half-life to KSM-66.
Pharmacokinetics No data
Pharmacokinetics data not available for this compound.
No half-life mentions found in the source notes.
What to expect Generic
  1. 1
    Week 1
    Tolerability and dose-response.
  2. 2
    Week 2-4
    Early effect window.
  3. 3
    Week 4-8
    Peak benefit assessment.
  4. 4
    Week 8+
    Cycle decision point.
Side effects + safety

Same as parent. Sensoril-specific notes:

  • Higher withaferin A → slightly higher theoretical autoimmune flare risk; case reports rare but Sensoril-associated
  • Daytime drowsiness if dosed AM
  • Hepatotoxicity case reports more often associated with Sensoril than KSM-66 (still rare; possibly publication bias from Sensoril's earlier market presence)
  • "Vivid dreams" common at higher PM doses
Interactions6 compounds
  • l-tryptophan / glycine (sleep stack):Synergistic
    Compound sleep-architecture support — but Dylan already has these
  • magnesium-glycinateSynergistic
    (Dylan's V4): GABAergic + Mg synergy
  • rhodiolaSynergistic
    (Dylan's V4): AM-rhodiola + PM-Sensoril is a sensible adaptogen split
  • l-theanineSynergistic
    (Dylan's V4): Additive evening calm
  • Other sedativesAvoid
    (benzos, alcohol, high-dose THC, melatonin >5 mg): Compound sedation
  • Thyroid hormone replacement, immunosuppressantsAvoid
    see parent
References4 sources
Was this helpful?
Your feedback shapes what we research deeper.
Continue: Extended Research →
Our verdict, decision matrix, deep dives, controversies, sources